My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Zymeworks Inc. - Common Stock (NY:ZYME)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Zymeworks Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now ↗

July 11, 2023

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

Via InvestorPlace

Over $27M Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying ↗

June 22, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

The 3 Most Undervalued Growth Stocks for Your June Buy List ↗

June 11, 2023

Sometimes you can get the best of both worlds in the equities sector, which should draw interest for these undervalued growth stocks.

Via InvestorPlace

7 Analysts Have This to Say About Zymeworks ↗

June 06, 2023

Via Benzinga

3 Cheap Growth Stocks That Are Too Good to Pass Up ↗

June 05, 2023

These top bargain growth stocks are all priced under $10 a share and offer real upside potential for investors.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

May 29, 2023

Via Benzinga

What 6 Analyst Ratings Have To Say About Zymeworks ↗

May 18, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

April 10, 2023

Via Benzinga

What 7 Analyst Ratings Have To Say About Zymeworks ↗

March 31, 2023

Via Benzinga

Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact ↗

March 20, 2023

Via Benzinga

Top 5 Health Care Stocks That May Collapse In Q2 ↗

May 10, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Earnings Scheduled For May 8, 2023 ↗

May 08, 2023

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.

Via Benzinga

The 7 Most Undervalued Stocks You Need to Know About ↗

April 18, 2023

Given the risks targeting highly popular trades right now, the most undervalued stocks to buy may offer greater mileage.

Via InvestorPlace

Analyst Ratings for Zymeworks ↗

March 08, 2023

Via Benzinga

Earnings Preview: Zymeworks ↗

March 06, 2023

Via Benzinga

$3M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

January 24, 2023

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Analyst Ratings for Zymeworks BC ↗

January 20, 2023

Via Benzinga

Jazz Pharma Opts In, Advances Zanidatamab Partnership With Zymeworks ↗

December 21, 2022

Via Benzinga

Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket ↗

March 08, 2023

Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1...

Via Benzinga

Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer ↗

January 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 19, 2023

Via Benzinga

Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket ↗

January 19, 2023

Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.

Via Benzinga

6 Analysts Have This to Say About Zymeworks BC ↗

December 20, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 19, 2023

We're starting off Thursday with an overview of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

Around $10M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗

January 19, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Around $8 Million Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying ↗

January 13, 2023

Although US stocks closed higher on Thursday, there were a few notable insider trades.

Via Benzinga

20 Favorite Biotech & Medical Stocks For 2023 ↗

December 28, 2022

The way these stocks are setting up, many of them look great and will be at the forefront this coming year.

Via Talk Markets

Alphabet To $115? Here Are 10 Other Price Target Changes For Thursday ↗

December 22, 2022

Stifel raised argenx SE (NASDAQ: ARGX) price target from $471 to $478. Stifel analyst Alex Thompson maintained a Buy rating on the stock. argenx shares rose 1.1% to $387.07 in pre-market trading.

Via Benzinga

Tesla, Amazon, Micron, Sintx, Zymeworks: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

December 21, 2022

U.S. markets soared on Wednesday as consumer confidence surged to an eight-month high in December following a drop in inflation and the labor market remaining strong. Twelve-month inflation...

Via Benzinga

Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session ↗

December 21, 2022

Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.